Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

protera

Protera is a biotechnology company that produce protein-based food ingredients.
2018
Nov-50
11-50
Neuilly-sur-seine, Ile-de-France, France

Innovation

Industry Problem

Food companies need faster, lower-cost ways to discover proteins and enzymes that improve product performance and sustainability.

R&D Focus

AI-designed proteins and enzymes for food applications

Innovative Solution

Protera builds functional ingredients for the food industry using protein engineering and artificial intelligence. Their agency streamlines protein design and development with a proprietary deep-learning algorithm, to predict high-value protein products and enzymes with unprecedented speed, enabling customers to get healthy, safe foods made from ingredients that are produced responsibly and sustainably.

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

15.6M

Last Funding Amount

10.M

Last Funding Date

28-07-2021

Startup Stage

Early Stage

Lead Investors

Sofinnova Partners, SOSV, IndieBio, Grupo Bimbo, ICL Group

Revenue

$1M to $10M

People

Founders

About

Protera builds functional ingredients for the food industry using protein engineering and artificial intelligence. Their agency streamlines protein design and development with a proprietary deep-learning algorithm, to predict high-value protein products and enzymes with unprecedented speed, enabling customers to get healthy, safe foods made from ingredients that are produced responsibly and sustainably.

Products

Product

MADI™ – an AI protein-design platform used to identify and optimize functional proteins and enzymes.

Star Product

MADI™ – the core computational platform behind Protera’s protein pipeline.

Demo Product or Complete Product?

Development-stage technology or ingredient platform; commercialization or clinical development is ongoing.

Future Plan

Investment Funding

$10M Series A closed in 2021, led by Sofinnova Partners with participation from ICL and other investors.

M&A and Collabs

Collab

ICL Food Specialties – joint development and commercialization of AI-designed, precision-fermented protein ingredients.

Something missing or incorrect on this page? Help us enrich this information